Latest Bacil Pharma stock price
Bacil Pharma P/E Ratio
BACPHAR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
75.28
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
75.28
Current Price
₹48.18
EPS (TTM)
₹0.64
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.35
Sector Median
26.63
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Bacil Pharma
- Stock appears overvalued with PE of 75.28, suggesting caution for new investments
- Trading at premium to sector average PE of 49.35
View the BACPHAR equity price for detailed stock performance.
Related Pages for Bacil Pharma
Additional stock information and data for BACPHAR
Sector P/E Ratio Comparison
Comparing Bacil Pharma with other companies in Healthcare sector
Sector Average
49.35
Sector Median
26.63
Lowest P/E
0.97
Highest P/E
993.26
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |